Quest for the right Drug
ספאם SPAM (ADAPALENE, CABOTEGRAVIR)
תרופה במרשם
תרופה בסל
נרקוטיקה
ציטוטוקסיקה
צורת מתן:
שאיפה : INHALATION
צורת מינון:
קפליות : CAPLETS
עלון לרופא
מינוניםPosology התוויות
Indications תופעות לוואי
Adverse reactions התוויות נגד
Contraindications אינטראקציות
Interactions מינון יתר
Overdose הריון/הנקה
Pregnancy & Lactation אוכלוסיות מיוחדות
Special populations תכונות פרמקולוגיות
Pharmacological properties מידע רוקחי
Pharmaceutical particulars אזהרת שימוש
Special Warning עלון לרופא
Physicians Leaflet
Adverse reactions : תופעות לוואי
4.8 Undesirable effects The safety of fentanyl IV was evaluated in 376 subjects who participated in 20 clinical trials evaluating fentanyl IV as an anaesthetic. These subjects took at least 1 dose of fentanyl IV and provided safety data. Based on pooled safety data from these clinical trials, the most commonly reported (≥5% incidence) Adverse Reactions were (with % incidence): nausea (26.1); vomiting (18.6); muscle rigidity (10.4); hypotension (8.8); hypertension (8.8); bradycardia (6.1); and sedation (5.3). Including the above-mentioned adverse reactions, Table 1 displays adverse reactions that have been reported with the use of fentanyl IV from either clinical trials or post- marketing experience. The displayed frequency categories use the following convention: Very common (≥1/10); common (≥1/100 to <1/10); uncommon (≥1/1,000 to <1/100); rare (≥1/10,000 to <1/1,000); very rare (<1/10,000); and not known (cannot be estimated from the available clinical trial data). Table 1: Adverse Reactions Adverse Reactions System Organ Frequency Category Class Very Common Uncommon Not Known Common (≥ 1/100 to < 1/10) (≥ 1/1,000 to < (≥ 1/10) 1/100) Immune System Hypersensitivity Disorders (such as anaphylactic shock, anaphylactic reaction, urticaria) Psychiatric Agitation Euphoric mood Delirium Disorders Drug dependence (see section 4.4) Nervous System Muscle Dyskinesia; Headache Convulsions; Disorders rigidity (which Sedation; Loss may also Dizziness of consciousness; involve the Myoclonus thoracic muscles) Eye Disorders Visual disturbance Cardiac Bradycardia; Cardiac arrest Disorders Tachycardia; Arrhythmia Vascular Hypotension; Phlebitis; Disorders Hypertension; Blood Venous pain pressure fluctuation Respiratory, Laryngospasm; Hyperventilation; Respiratory Thoracic Bronchospasm; Hiccups depression and Mediastinal Apnoea Disorders Gastrointestinal Nausea; Disorders Vomiting Skin and Allergic dermatitis Pruritus Subcutaneous Tissue Disorders General Chills; Drug withdrawal Disorders and Hypothermia syndrome (see Administration Drug withdrawal section 4.4) Site Conditions syndrome Injury, Poisoning Postoperative Airway and Procedural confusion complication Complications of anaesthesia When a neuroleptic is used with fentanyl, the following adverse reactions may be observed: chills and/or shivering, restlessness, postoperative hallucinatory episodes and extrapyramidal symptoms (see Section 4.4). Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Any suspected adverse events should be reported to the Ministry of Health according to the National Regulation by using an online form: https://sideeffects.health.gov.il
שימוש לפי פנקס קופ''ח כללית 1994
לא צוין
תאריך הכללה מקורי בסל
לא צוין
הגבלות
לא צוין
ATC
מידע נוסף
עלון מידע לרופא
20.08.23 - עלון לרופאעלון מידע לצרכן
31.05.23 - עלון לצרכן עברית 25.05.23 - עלון לצרכן ערבית 18.05.23 - עלון לצרכן 20.08.23 - עלון לצרכן אנגלית 31.10.23 - עלון לצרכן עברית 26.11.23 - עלון לצרכן עברית 04.07.23 - החמרה לעלון 17.05.23 - החמרה לעלון 17.05.23 - החמרה לעלון 17.05.23 - החמרה לעלון 30.05.23 - החמרה לעלון 06.07.23 - החמרה לעלון 19.10.23 - החמרה לעלוןלתרופה במאגר משרד הבריאות
ספאם